In vitro studies on interferon-inducing capacity and sensitivity to IFN of human foamy virus

Research in Virology

Volumn 147, Issue 1, 1996, Pages 29-37

  Sabile, A ^a   Rhodes Feuillette, A ^a   Jaoui, F Z ^a   Tobaly Tapiero, J ^a   Giron, M L ^a   Lasneret, J ^a   Peries J ^a   Canivet, M ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Human foamy virus; Human , and IFN; IFN; Retrovirus

Indexed keywords

BETA INTERFERON; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERFERON; RECOMBINANT PROTEIN; VIRUS PROTEIN; ALPHA INTERFERON; GAMMA INTERFERON; INTERFERON; RNA DIRECTED DNA POLYMERASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CHEMISTRY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; PAPIO; SPUMA VIRUS; ANTIVIRAL ACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS REPLICATION;

ANIMALS; CELL LINE; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-BETA; INTERFERON-GAMMA, RECOMBINANT; PAPIO; RECOMBINANT PROTEINS; SPUMAVIRUS; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

ANIMALIA; HUMAN FOAMY VIRUS; HUMAN SPUMARETROVIRUS; PAPIO HAMADRYAS; SPUMAVIRUS;

EID: 0029670410     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2516(96)80237-8     Document Type: Article

References (40)

1. Achong, B.G., Mansell, P.W., Epstein, M.A. & Clifford, P. (1971), An unusual virus in cultures from a human nasopharyngial carcinoma. J. Natl. Cancer Inst., 46, 299-307.
2. Baca-Regen, L., Heinzinger, N., Stevenson, M. & Gendelman, H.E. (1994), Alpha interferon-induced antiretroviral activities : restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type I-infected monocytes. J. Virol., 68, 7559-7565.
3. Billau, A., Heremans, H., Allen, P.T., de Maeyer-Guignard, J. & de Sommer, P. (1976), Trapping of oncornavirus particles at the surface of interferon-treated cells. Virology, 73, 537-542.
4. Canivet, M., Jouanny, C., Fourcade, A., Lasneret, J., Rhodes-Feuillette, A. & Périès, J. (1983), Effect of human interferon on type D retroviruses multiplication in chronically infected cell lines. J. Interferon Res., 3, 53-64.
5. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. & Rutter, W.J. (1979), Isolation of biologically active ribonucleic acid from source enriched in ribonuclease. Biochemistry, 18, 5294-5299.
6. Cullen, B.R. (1992), Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev., 56, 375-394.
7. Coccia, E.M., Krust, B. & Hovanessian, A.G. (1994), Specific inhibition of viral protein synthesis in HIV-infected cells in reponse to interferon treatment. J. Biol. Chem., 269, 23087-23094.
8. Coffin, J.M. (1991), Classification and Nomenclature of Viruses. Fith Report of the International Commitee on Taxonomy of Viruses, in "Arch. Virol." Suppl. 2 (Francki, R.I.B., Fauquet, C.M., Knudson, D.L., Brown, F.) (pp. 290-299) Springer-Verlag Wien, New York.
9. Debons-Guillemin, M.C., Valla, J., Gazeau, J., Wybier-Franqui, J., Giron, M.L., Toubert, M.E., Canivet, M. & Périès, J. (1992), No evidence of spumaretrovirus markers in 19 cases of the De Quervain's thyroiditis. Aids Res. Hum. Retroviruses, 8, 1547.
10. Feinberg, A.P. & Vogelstein, B. (1983), A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13.
11. Flügel, R.M., Rethwilm, A., Maurer, B. & Darai, G. (1987), Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. EMBO J., 6, 2077-2084.
12. Gessani, S., Puddu, P., Varano, B., Borghi, P., Conti, L. & Fantuzzi, L. (1994), Induction of beta interferon by human immunodeficiency virus type I and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication. J. Virol., 68, 1983-1986.
13. Giron, M.L., Rozain, F., Debons-Guillemin, M.C., Canivet, M., Périès, J. & Emanoil-Ravier, R. (1993), Human foamy virus polypeptides. J. Virol., 67, 3596-3600.
14. Gross-Bellard, M., Oudet, P. & Chambon, P. (1973), Isolation of high molecular weight DNA from mammalian cells. Eur. J. Biochem., 36, 32-38.
15. Hirt, B. (1967), Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol., 26, 365-369.
16. Jocklik, W.K. (1990), Interferons, in "Virology" (Fields, B.N. and Knipe, D.N.) (pp. 383-410). Press New York.
17. Lagaye, S., Vexiau, P., Morozov, V., Saal, F., Gony, J., Porters, A.M., Loosfelt-Poirot, Y., Hors, J., Cathelineau, G., Emanoil, R. & Périès, J. (1991), Detection of HTLV-I gag related sequence in leukocyte DNA from patients with polyendocrinopathies (Basedow-Graves' disease and insulin-dependent diabetes). C.R. Acad. Sci., 312, 309-315.
18. Loh, P.C. (1993), Spumaviruses, in "The Retroviridae.2" (Levy, J.A.) (pp. 361-397) Plenum Press, New York.
19. Lycke, J., Svennerholm, J., Svenningsson, A., Muranyi, W., Flügel, R.M. & Andersen, O. (1994), Human spumaretrovirus antibody reactivity in multiple sclerosis. J. Neurol., 241, 204-209.
20. Macé, K., Due Dodon, M. & Gazzolo, L. (1989), Restriction of HTV-1 replication in promonocytic cells: A role for IFN-α. Virology, 168, 399-405.
21. Maurer, A.P., Bannert, H., Darai, G. & Flügel, R.M. (1988), Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J. Virol., 62, 1590-1597.
22. Meinkoth, J. & Wahl, C. (1984), Hybridization of nucleic acids immobilized on solid supports. Anal. Biochem., 132, 267-284.
23. Narayan, O., Sheffer, D., Clement, I.E. & Tennekon, G. (1985), Visna induces a unique interferon during interaction between lymphocytes and infected macrophages. J. Exp. Med., 162, 195-196.
24. Périès, J., Boiron, M. & Canivet, M. (1965), Recherche d'une production d'interféron et d'une interférence virale hétérologue dans une lignée cellulaire chroniquement infectée par le virus de Rausher. Ann. Inst. Pasteur (Paris), 6362-6364.
25. Périès, J., Canivet, M., Rhodes-Feuillette, A. & Todaro, G. (1979), Effect of interferon on chronic infection of human cells by xenotropic type C viruses. Int. J. Cancer, 2, 798-802.
26. Pitha, P.M. (1994), Multiple effects of interferon on the replication of human immunodeficiency virus type I. Antiviral Res., 24, 205-219.
27. Rhodes-Feuillette, A., Cavalieri, F., Canivet, M. & Périès, J. (1979), Effet de l'interferon humain sur la production virale d'une lignée cellulaire chroniquement infectée par un retrovirus de type D (virus de Mason-Pfizer). C.R. Acad. Sci., 288, 1239-1241.
28. Rhodes-Feuillette, A., Saal, F., Lasneret, J., Santillana-Hayat, M. & Périès, J. (1987), Studies on in vitro interferon sensitivity of simian foamy viruses. Arch. Virol., 97, 77-84.
29. Saib, A., Canivet, M., Giron, M.L., Bolgert, F., Valla, J., Lagaye, S., Périès, J. & de Thé, H. (1994), J. Human foamy virus infection in myasthenia gravis. Lancet, 343, 666.
30. Santillana-Hayat, M., Rozain, F., Bittoun, P., Chopin-Robert, C., Lasneret, J., Périès, J. & Canivet, M. (1993), Transient immunosuppressive effect induced in rabbits and mice by the human spumaretrovirus prototype HFV (human foamy virus). Res. Virol., 144, 389-396.
31. Schweizer, M., Turek, R., Reinhardt, M. & Neumann-Haefelin, D. (1994), Absence of foamy DNA in Graves' disease. AIDS Res. Hum. Retroviruses, 10, 601-605.
32. Shirazi, Y. & Pitha, P. (1992), Alpha interferon inhibits early states of the human immunodeficiency virus type I replication cycle. J. Virol. 66, 1321-1328.
33. Southern, E.M. (1975), Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98, 503-517.
34. Stancek, D. & Gressnerova, M. (1974), A viral agent isolated from a patient with a subacute De Quervain type thyroidis. Acta Virol., 18, 365.
35. Szebeni, J., Dieffenbach, C., Wahl, S.M., Venkateshan, C.N., Yeh, A., Popovic, M., Gartner, S., Wahl, L.M., Perterfy, M., Friedman, R.M. & Weinstein, J.N. (1991), Induction of alpha interferon by human immunodeficiency virus type I in human monocyte-macrophage cultures. J. Virol., 73, 537-542.
36. Thomas, P.S. (1983), Hybridization of denatured RNA transferred or dotted to nitrocellulose paper. Methods enzymol., 100B, 255-266.
37. Tobaly-Tapiero, J., Santillana-Hayat, M., Giron, M.L., Guillemin, M.C., Rozain, F., Périès, J. & Emanoil-Ravier, R. (1990), Molecular differences between two immunologically related spumaretroviruses: the human prototype HSRV and the chimpanzee isolate SFV6. Aids Res. Hum. Retroviruses, 6, 951-957.
38. Westarp, M.E., Föhring, B., Rasmussen, H., Schraff, S., Mertens, T. & Kornhuber, H.H. (1994), Retroviral synthetic peptide serum antibodies in human sporadic amyotrophic lateral sclerosis. Peptides, 15, 207-214.
39. Wick, G., Grubeck-Loebenstein, B., Trieb, K., Kalishnig, G. & Aguzzi, A. (1992), Human foamy virus antigens in thyroid tissue of Graves' disease patients. Arch. Allergy Immunol., 99, 153-156.
40. Wybier-Franqui, J., Tobaly-Tapiero, J., Coronel, A., Giron, M.L., Chopin-Robert, C., Périès, J. & Emanoil-Ravier, R. (1995), Human foamy virus (HFV) DNA forms and expression in persistently infected Dami megakaryocytic cells. Aids Res. Hum. Retroviruses, 11, 829-836.